T&R Biofab Co., Ltd. (KOSDAQ: 246710)
South Korea
· Delayed Price · Currency is KRW 5,900.00
-40.00 (-0.67%)
Nov 15, 2024, 9:00 AM KST
T&R Biofab Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 4,937 | 5,199 | 5,755 | 3,235 | 6,805 | 1,287 | Upgrade
|
| Other Revenue | - | -0 | -0 | - | - | - | Upgrade
|
| Revenue | 4,937 | 5,199 | 5,755 | 3,235 | 6,805 | 1,287 | Upgrade
|
| Revenue Growth (YoY) | -8.46% | -9.65% | 77.90% | -52.47% | 428.71% | 32.11% | Upgrade
|
| Cost of Revenue | 3,577 | 4,151 | 4,236 | 3,469 | 4,162 | 698.91 | Upgrade
|
| Gross Profit | 1,360 | 1,048 | 1,519 | -234.3 | 2,643 | 588.21 | Upgrade
|
| Selling, General & Admin | 7,552 | 7,024 | 8,676 | 5,109 | 4,138 | 4,424 | Upgrade
|
| Research & Development | 5,255 | 4,399 | 3,857 | 3,285 | 2,951 | 2,230 | Upgrade
|
| Other Operating Expenses | 240.41 | 227.69 | 253.58 | 148.71 | 119.12 | 102.89 | Upgrade
|
| Operating Expenses | 16,174 | 13,902 | 14,242 | 10,444 | 8,152 | 7,448 | Upgrade
|
| Operating Income | -14,814 | -12,853 | -12,723 | -10,678 | -5,509 | -6,860 | Upgrade
|
| Interest Expense | -1,238 | -3.24 | -1.9 | -2,601 | -35.78 | -46.01 | Upgrade
|
| Interest & Investment Income | 1,822 | 1,676 | 1,199 | 463.61 | 245.22 | 506.97 | Upgrade
|
| Currency Exchange Gain (Loss) | 3.99 | 0.97 | 11.63 | 45.29 | -188.64 | 2.87 | Upgrade
|
| Other Non Operating Income (Expenses) | 3,989 | -1,424 | 1,062 | -57,552 | -159.28 | 186.01 | Upgrade
|
| EBT Excluding Unusual Items | -10,237 | -12,604 | -10,453 | -70,323 | -5,647 | -6,210 | Upgrade
|
| Gain (Loss) on Sale of Investments | -669.59 | 5.26 | 129.95 | 431.52 | 42.83 | -41.17 | Upgrade
|
| Gain (Loss) on Sale of Assets | -5.93 | -0.14 | -14.3 | - | 0.28 | - | Upgrade
|
| Asset Writedown | -195.49 | -195.49 | - | -176.5 | - | - | Upgrade
|
| Other Unusual Items | -3,261 | -625.01 | - | - | - | - | Upgrade
|
| Pretax Income | -14,369 | -13,419 | -10,337 | -70,068 | -5,604 | -6,251 | Upgrade
|
| Net Income | -14,369 | -13,419 | -10,337 | -70,068 | -5,604 | -6,251 | Upgrade
|
| Net Income to Common | -14,369 | -13,419 | -10,337 | -70,068 | -5,604 | -6,251 | Upgrade
|
| Shares Outstanding (Basic) | 21 | 21 | 21 | 18 | 8 | 8 | Upgrade
|
| Shares Outstanding (Diluted) | 21 | 21 | 21 | 18 | 8 | 8 | Upgrade
|
| Shares Change (YoY) | 1.35% | 1.74% | 17.19% | 112.29% | 0.91% | 20.45% | Upgrade
|
| EPS (Basic) | -671.96 | -632.85 | -496.00 | -3940.00 | -669.00 | -753.00 | Upgrade
|
| EPS (Diluted) | -671.96 | -632.85 | -496.00 | -3940.00 | -669.00 | -753.00 | Upgrade
|
| Free Cash Flow | -15,159 | -19,456 | -16,712 | -8,689 | -10,063 | -5,842 | Upgrade
|
| Free Cash Flow Per Share | -708.92 | -917.57 | -801.91 | -488.60 | -1201.18 | -703.70 | Upgrade
|
| Gross Margin | 27.54% | 20.16% | 26.39% | -7.24% | 38.84% | 45.70% | Upgrade
|
| Operating Margin | -300.05% | -247.22% | -221.10% | -330.12% | -80.95% | -532.94% | Upgrade
|
| Profit Margin | -291.04% | -258.10% | -179.63% | -2166.15% | -82.36% | -485.66% | Upgrade
|
| Free Cash Flow Margin | -307.05% | -374.22% | -290.42% | -268.63% | -147.87% | -453.86% | Upgrade
|
| EBITDA | -12,437 | -10,697 | -10,776 | -8,936 | -4,240 | -6,045 | Upgrade
|
| EBITDA Margin | -251.90% | -205.74% | -187.25% | -276.25% | -62.31% | - | Upgrade
|
| D&A For EBITDA | 2,377 | 2,156 | 1,948 | 1,743 | 1,269 | 814.37 | Upgrade
|
| EBIT | -14,814 | -12,853 | -12,723 | -10,678 | -5,509 | -6,860 | Upgrade
|
| EBIT Margin | - | -247.22% | -221.10% | - | -80.95% | - | Upgrade
|
| Advertising Expenses | - | 267.47 | 442.63 | 277.35 | 240.77 | 342.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.